The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Biologic therapy of inflammatory bowel disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Self-citationLymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Self-citationFiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Self-citationIL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
ICOS co-stimulatory receptor is essential for T-cell activation and function
Dong, C., Juedes, A. E., Temann, U.-A., Shresta, S., Allison, J. P., Ruddle, N. H., & Flavell, R. A. (2001) · Nature · doi:10.1038/35051100 · Cited by 936
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Self-citationNeurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
T-cell co-stimulation through B7RP-1 and ICOS
Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G., Zhang, M., Coccia, M. A., Kohno, T., et al. (1999) · Nature · doi:10.1038/45582 · Cited by 777
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
Role of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
Papadakis, K. A., & Targan, S. R. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.289 · Cited by 714
Self-citationICOS is essential for effective T-helper-cell responses
Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A., Boucher, L.-M., Bouchard, D., Chan, V. S. F., Duncan, G., et al. (2001) · Nature · doi:10.1038/35051113 · Cited by 675
Scallon, B. (1995) · Cytokine · doi:10.1006/cyto.1995.0029 · Cited by 675
NAKANISHI, K., YOSHIMOTO, T., TSUTSUI, H., & OKAMURA, H. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00015-0 · Cited by 662
ICOS is critical for CD40-mediated antibody class switching
McAdam, A. J., Greenwald, R. J., Levin, M. A., Chernova, T., Malenkovich, N., Ling, V., Freeman, G. J., & Sharpe, A. H. (2001) · Nature · doi:10.1038/35051107 · Cited by 647
Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J., & Cominelli, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6829 · Cited by 572
The interferons. Mechanisms of action and clinical applications
Baron, S. (1991) · JAMA · doi:10.1001/jama.266.10.1375 · Cited by 569
Romagnani, S. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00009 · Cited by 520
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Tumour necrosis factor and Crohn's disease.
Van Deventer, S. J. (1997) · Gut · doi:10.1136/gut.40.4.443 · Cited by 500
van Deventer, S., Elson, C., & Fedorak, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247454 · Cited by 486
Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A., & Alber, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260722 · Cited by 469
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430207 · Cited by 468
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
Inhibition of p38 MAP kinase as a therapeutic strategy
Lee, J. C., Kumar, S., Griswold, D. E., Underwood, D. C., Votta, B. J., & Adams, J. L. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00206-x · Cited by 455
Sandborn, W. J., & Hanauer, S. B. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00008 · Cited by 454
Self-citationInfliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Self-citationInterleukin-11: Review of Molecular, Cell Biology, and Clinical Use
Du, X., & Williams, D. A. (1997) · Blood · doi:10.1182/blood.v89.11.3897 · Cited by 392
The Interferons: Mechanisms of Action and Clinical Applications
Baron, S. (1991) · JAMA · doi:10.1001/jama.1991.03470100067035 · Cited by 392
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease
Stack, W., Mann, S., Roy, A., Heath, P., Sopwith, M., Freeman, J., Holmes, G., Long, R., Forbes, A., Kamm, M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80083-9 · Cited by 384
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
Yacyshyn, B. R., Bowen-Yacyshyn, M. B., Jewell, L., Tami, J. A., Bennett, C. F., Kisner, D. L., & Shanahan, W. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70418-4 · Cited by 381
Hommes, D., Van Den Blink, B., Plasse, T., Bartelsman, J., Xu, C., Macpherson, B., Tytgat, G., Peppelenbosch, M., & Van Deventer, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.30770 · Cited by 378
T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo
Cottrez, F., Hurst, S. D., Coffman, R. L., & Groux, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4848 · Cited by 366
Therapeutic monoclonal antibodies
Breedveld, F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)01034-5 · Cited by 359
Tumor necrosis factor: Biology and therapeutic inhibitors
Papadakis, K. A., & Targan, S. R. (2000) · Gastroenterology · doi:10.1053/gast.2000.18160 · Cited by 357
Self-citationStanding, O. (2002) · Cited by 351
Role of NF-κB in immune and inflammatory responses in the gut
NEURATH, M. F., BECKER, C., & BARBULESCU, K. (1998) · Gut · doi:10.1136/gut.43.6.856 · Cited by 349
Keratinocyte Growth Factor: A Unique Player in Epithelial Repair Processes
Werner, S. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00010-0 · Cited by 347
Duchmann, R., Schmitt, E., Knolle, P., Zum Büschenfelde, K. M., & Neurath, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260432 · Cited by 345
Characterization of the cell surface heterodimer VLA-4 and related peptides.
Hemler, M. E., Huang, C., Takada, Y., Schwarz, L., Strominger, J. L., & Clabby, M. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60831-2 · Cited by 335
Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy
(2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441415 · Cited by 330
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
Ehrenpreis, E. D., Kane, S. V., Cohen, L. B., Cohen, R. D., & Hanauer, S. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70276-3 · Cited by 326
Hesterberg, P., Winsor-Hines, D., Briskin, M., Soler-Ferran, D., Merrill, C., Mackay, C., Newman, W., & Ringler, D. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898653 · Cited by 323
Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.
Podolsky, D. K., Lobb, R., King, N., Benjamin, C. D., Pepinsky, B., Sehgal, P., & deBeaumont, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116575 · Cited by 320
Gordon, F. H., Lai, C. W. Y., Hamilton, M. I., Allison, M. C., Srivastava, E. D., Fouweather, M. G., Donoghue, S., Greenlees, C., Subhani, J., Amlot, P. L., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.26260 · Cited by 314
Tumour-necrosis-factor antibody treatment in Crohn's disease
Derkx, B., Taminiau, J., Radema, S., Stronkhorst, A., Wortel, C., Tytgat, G., & van Deventer, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91375-v · Cited by 308
Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H.-A., Hartmann, G., Dinarello, C. A., Endres, S., & Eigler, A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.4.r1264 · Cited by 288
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03612.x · Cited by 285
Self-citationVasiliauskas, E. A., Kam, L. Y., Abreu-Martin, M. T., Hassard, P. V., Papadakis, K. A., Yang, H., Zeldis, J. B., & Targan, S. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70277-5 · Cited by 281
Self-citationAnti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
Fuss, I. J., Marth, T., Neurath, M. F., Pearlstein, G. R., Jain, A., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70392-6 · Cited by 268
Selby, W. S., Janossy, G., Bofill, M., & Jewell, D. P. (1984) · Gut · doi:10.1136/gut.25.1.32 · Cited by 267
Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Present, D. H., Sutherland, L. R., Kamm, M. A., Wolf, D. C., Baker, J. P., Hawkey, C., Archambault, A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24042 · Cited by 257
Self-citationInterleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
Colombel, J.-F., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O. H., Rask-Madsen, J., Van Deventer, S., Ferguson, A., Desreumaux, P., Forbes, A., et al. (2001) · Gut · doi:10.1136/gut.49.1.42 · Cited by 240
Infliximab in Crohn's Disease: First Anniversary Clinical Experience
Cohen, R. D., Tsang, J. F., & Hanauer, S. B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03363.x · Cited by 229
XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation
Rennick, D. M., & Fort, M. M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g829 · Cited by 225
Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., Sandborn, W. J., Lipsky, J. J., & McKean, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26448 · Cited by 217
Self-citationA Preliminary Study of Growth Hormone Therapy for Crohn's Disease
Slonim, A. E., Bulone, L., Damore, M. B., Goldberg, T., Wingertzahn, M. A., & McKinley, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422203 · Cited by 205
Schreiber, S., MacDermott, R. P., Raedler, A., Pinnau, R., Bertovich, M. J., & Nash, G. S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90729-5 · Cited by 204
Sands, B. E., Bank, S., Sninsky, C. A., Robinson, M., Katz, S., Singleton, J. W., Miner, P. B., Safdi, M. A., Galandiuk, S., Hanauer, S. B., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70550-0 · Cited by 204
The relationship between infliximab treatment and lymphoma in Crohn's disease
Bickston, S. J., Lichtenstein, G. R., Arseneau, K. O., Cohen, R. B., & Cominelli, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70294-5 · Cited by 203
Recent Developments in the Immunology of Inflammatory Bowel Disease
Macdonald, Monteleone, & Pender (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00658.x · Cited by 197
Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand
Mages, H. W., Hutloff, A., Heuck, C. J., Büchner, K., Himmelbauer, H., Oliveri, F., & Kroczek, R. A. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<1040::aid-immu1040>3.0.co;2-6 · Cited by 193
Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease
Schreiber, S., Nikolaus, S., Malchow, H., Kruis, W., Lochs, H., Raedler, A., Hahn, E. G., Krummenerl, T., & Steinmann, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.24015 · Cited by 186
Growth Factors in Inflammatory Bowel Disease
Beck, P. L., & Podolsky, D. K. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199902000-00007 · Cited by 180
Sands, B. E., Winston, B., Salzberg, B. A., Safdi, M. A., Barish, C. F., Wruble, L. D., Wilkins, R., Shapiro, M. A., Schwertschlag, U. S., & THE RHIL‐11 CROHN'S STUDY GROUP (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01179.x · Cited by 148
Hirata, I., Berrebi, G. A., Austin, L. L., Keren, D. F., & Dobbins, W. O. (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01318690 · Cited by 143
Infliximab for refractory ulcerative colitis
Chey, W. Y., Hussain, A., Ryan, C., Potter, G. D., & Shah, A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04039.x · Cited by 138
Successful management of Crohn's disease of the ileoanal pouch with infliximab
Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900429 · Cited by 134
Self-citationTreatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571
Evans, R. C., CLARKE, L., Heath, P. K., Stephens, S., Morris, A. I., & Rhodes, J. M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00251.x · Cited by 131
NF-κB Signaling Proteins as Therapeutic Targets for Inflammatory Bowel Diseases
Jobin, C., & Sartor, R. B. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200008000-00007 · Cited by 130
IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology.
Keith, J. J., Albert, L. M., Sonis, S. T., Cj, P., & Schaub, R. (1994) · PubMed · Cited by 127
Antisense-Oligonucleotide Therapy
Askari, F. K., & McDonnell, W. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340508 · Cited by 124
Léger, O., Yednock, T. A., Tanner, L., et al. (1997) · Human Antibodies · doi:10.3233/hab-1997-8102 · Cited by 119
Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats
Qiu, B., Pfeiffer, C. J., & Keith, J. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02087911 · Cited by 117
Is Crohn's Disease an Immunodeficiency?
Korzenik, J. R., & Dieckgraefe, B. K. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005541700805 · Cited by 114
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.
Stronkhorst, A., Radema, S. A., Yong, S. L., Bijl, H. M., ten Berge, I. J. M., Tytgat, G. N. J., & van Deventer, S. J. H. (1997) · Gut · doi:10.1136/gut.40.3.320 · Cited by 107
Remission of Crohn's Disease After Human Immunodeficiency Virus Infection
James, S. P. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80094-5 · Cited by 107
Farstad, I. N., Halstensen, T. S., Kvale, D., FAUSA, O., & Brandtzaeg, P. (1997) · PubMed Central · Cited by 97
Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody
Emmrich, J., Seyfarth, M., Fleig, W. E., & Emmrich, F. (1991) · The Lancet · doi:10.1016/0140-6736(91)91133-f · Cited by 92
Cong, Y., Weaver, C. T., Lazenby, A. J., & Elson, C. O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2173 · Cited by 90
An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC)
Feagan, B. G., McDonald, J., Greenberg, G. R., Wild, G., Paré, P., Fedorak, R. N., Landau, S. B., & Brettrnan, L. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85637-1 · Cited by 90
Han, D. S., Li, F., Holt, L. C., Connolly, K. M., Hubert, M., Miceli, R. C., Okoye, Z., Santiago, G., Windle, K., Wong, E., et al. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g1011 · Cited by 89
Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases
Salituro, F. G., Germann, U. A., Wilson, K. P., Bemis, G. W., Fox, T., & Su, M. S. S. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401150415 · Cited by 87
Madsen, S. M., Schlichting, P., Davidsen, B., Nielsen, O. H., Federspiel, B., Riis, P., & Munkholm, P. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02438-8 · Cited by 81
Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial
D’Haens, G., Swijsen, C., Noman, M., Lemmens, L., Ceuppens, J. L., Agbahiwe, H. C., Geboes, K. J., & Rutgeerts, P. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04705.x · Cited by 78
Feagan, B. G., Sandborn, W. J., Baker, J. P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)84761-7 · Cited by 77
Self-citationBiologic Therapy for Inflammatory Bowel Disease
Sands, B. E. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030206 · Cited by 60
Efficacy of Keratinocyte Growth Factor-2 in Dextran Sulfate Sodium-Induced Murine Colitis
Miceli, R. C., Hubert, M., Santiago, G., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34921-3 · Cited by 54
Prospective evaluation of interferon-α in treatment of chronic active Crohn's disease
Gasché, C., Reinisch, W., Vogelsang, H., Pötzi, R., Markis, V., Micksche, M., Wirth, H., Gangl, A., & Lochs, H. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064982 · Cited by 50
Rogler, G., Hausmann, M., Spöttl, T., Vogl, D., Aschenbrenner, E., Andus, T., Falk, W., Schölmerich, J., & Groß, V. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199910000-00006 · Cited by 49
Katz, J., Lichtenstein, G. R., Keenan, G. F., Healy, D. E., & Jacobs, S. J. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)80343-5 · Cited by 37
Interleukin-10 in the intestine
Schreiber, S. (1997) · Gut · doi:10.1136/gut.41.2.274 · Cited by 18
Korzenik, J. R., & DIECKGRAETE, B. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)81376-5 · Cited by 16
Yacyshyn, B., CHEY, W. Y., Goff, J. S., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)81386-8 · Cited by 9
Cited by
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Self-citationEosinophilic gastrointestinal disorders (EGID)
Rothenberg, M. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.047 · Cited by 923
Beaugerie, L., Seksik, P., Nion–Larmurier, I., Gendre, J., & Cosnes, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.019 · Cited by 860
Importance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 602
Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium
Kim, K.-A., Kakitani, M., Zhao, J., Oshima, T., Tang, T., Binnerts, M., Liu, Y., Boyle, B., Park, E., Emtage, P., et al. (2005) · Science · doi:10.1126/science.1112521 · Cited by 586
Metadata
- Authors
- Sandborn, W. J., & Targan, S. R.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 122
- Issue
- 6
- Pages
- 1592-1608
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1965614926
- Cited by
- 344
- References
- 110
- FWCI
- 21.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.